Avacta Group Plc
Avacta Group Plc, together with its subsidiaries, engages in the development of cancer therapies in the United Kingdom, South Korea, and internationally. Its lead product candidate is AVA6000, a peptide drug conjugate form of doxorubicin, which is an approved cancer drug with known severe toxicities. The company is developing AVA6103, a peptide drug conjugate technology designed to deliver exatec… Read more
Avacta Group Plc (AVCTF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -128.776x
Based on the latest financial reports, Avacta Group Plc (AVCTF) has a cash flow conversion efficiency ratio of -128.776x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-18.54 Million) by net assets ($144.00K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Avacta Group Plc - Cash Flow Conversion Efficiency Trend (2000–2024)
This chart illustrates how Avacta Group Plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Avacta Group Plc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Avacta Group Plc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Jack In The Box Inc
NASDAQ:JACK
|
-0.036x |
|
Utah Medical Products Inc
NASDAQ:UTMD
|
0.033x |
|
Xiangtan Yongda Mach Mnfg Co
SHE:001239
|
N/A |
|
Pharmagest Interactive
LSE:0R9T
|
0.191x |
|
Blue Acquisition Corp. Class A Ordinary Shares
NASDAQ:BACC
|
0.000x |
|
OKEA A.S. NK-1
F:3SX
|
N/A |
|
Calix Limited
PINK:CLXLF
|
N/A |
|
Jupiter Mines Ltd
AU:JMS
|
0.001x |
Annual Cash Flow Conversion Efficiency for Avacta Group Plc (2000–2024)
The table below shows the annual cash flow conversion efficiency of Avacta Group Plc from 2000 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $9.28 Million | $-23.60 Million | -2.543x | -272.78% |
| 2023-12-31 | $21.80 Million | $-14.87 Million | -0.682x | +23.47% |
| 2022-12-31 | $18.44 Million | $-16.43 Million | -0.891x | -79.16% |
| 2021-12-31 | $41.22 Million | $-20.51 Million | -0.497x | -189.48% |
| 2020-12-31 | $61.93 Million | $-10.64 Million | -0.172x | +41.83% |
| 2019-12-31 | $25.81 Million | $-7.62 Million | -0.295x | 0.00% |
| 2019-07-31 | $25.81 Million | $-7.62 Million | -0.295x | -15.68% |
| 2018-12-31 | $21.41 Million | $-5.47 Million | -0.255x | -79.97% |
| 2017-12-31 | $29.89 Million | $-4.24 Million | -0.142x | -20.19% |
| 2016-12-31 | $35.86 Million | $-4.23 Million | -0.118x | +10.19% |
| 2015-12-31 | $19.13 Million | $-2.52 Million | -0.131x | -352.36% |
| 2014-12-31 | $28.84 Million | $-838.00K | -0.029x | +67.18% |
| 2013-12-31 | $15.55 Million | $-1.38 Million | -0.089x | -111.16% |
| 2012-12-31 | $16.96 Million | $-711.00K | -0.042x | +19.54% |
| 2011-12-31 | $11.44 Million | $-596.00K | -0.052x | +70.16% |
| 2010-12-31 | $9.97 Million | $-1.74 Million | -0.175x | +48.24% |
| 2009-12-31 | $8.30 Million | $-2.80 Million | -0.337x | -26.84% |
| 2008-12-31 | $4.87 Million | $-1.29 Million | -0.266x | +44.06% |
| 2007-12-31 | $2.63 Million | $-1.25 Million | -0.475x | +95.21% |
| 2005-12-31 | $14.00K | $-139.00K | -9.929x | -148.21% |
| 2004-12-31 | $21.00K | $-84.00K | -4.000x | -916.22% |
| 2003-12-31 | $1.03 Million | $-407.00K | -0.394x | -315.55% |
| 2002-12-31 | $-230.00K | $-42.00K | 0.183x | -8.87% |
| 2001-12-31 | $-529.00K | $-106.00K | 0.200x | -47.29% |
| 2000-12-31 | $-363.00K | $-138.00K | 0.380x | -- |